Temporal RAGE Over-Expression Disrupts Lung Development by Modulating Apoptotic Signaling

Derek M Clarke1, Madison N Kirkham1, Logan B Beck1

  • 1Department of Cell Biology and Physiology, Brigham Young University, 3054 Life Sciences Building, Provo, UT 84602, USA.

PubMed

Insights

Receptors for advanced glycation end products (RAGE) significantly impact lung development. Early RAGE overexpression causes severe tissue loss and structural damage, highlighting its critical role in lung formation.

Area of Science:

  • Cell Biology
  • Developmental Biology
  • Molecular Biology

Background:

  • Receptors for advanced glycation end products (RAGE) are cell surface receptors abundant in lung tissue.
  • RAGE plays a role in various physiological and pathological processes.
  • Its specific role in lung development requires further elucidation.

Purpose of the Study:

  • To investigate the role of RAGE in lung development using a transgenic mouse model.
  • To determine the impact of spatiotemporal RAGE overexpression on lung histology and molecular pathways.

Main Methods:

  • Utilized a transgenic (TG) mouse model with controlled RAGE overexpression.
  • Performed histological imaging to assess lung structure.
  • Analyzed molecular markers of apoptosis, cell survival, and cell cycle regulation.

Main Results:

  • RAGE upregulation from embryonic day (E) 15.5 to E18.5 led to thickened alveolar parenchyma and reduced surface area.
  • RAGE overexpression from E0 to E18.5 resulted in significant tissue loss and architectural disruption.
  • Mitochondrial dysfunction, dysregulated intrinsic and extrinsic apoptosis, and altered cell survival/cycle pathways were observed.

Conclusions:

  • RAGE is a pivotal modulator of lung development.
  • The timing of RAGE upregulation critically influences lung development outcomes and histological phenotypes.
  • RAGE signaling may contribute to developmental lung diseases.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.3K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
2.7K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
4.9K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K